Prognostic value of the baseline 18F-FDG PET/CT metabolic tumour volume (MTV) and further stratification in low-intermediate (L-I) and high-intermediate (H-I) risk NCCNIPI subgroup by MTV in DLBCL MTV predict prognosis in DLBCL

INTRODUCTION: In the era of rituximab, the NCCNIPI is widely used in clinical practice as a tool for the prognosis and risk stratification of diffuse large B-cell lymphoma (DLBCL). In recent years, FDG PET/CT has also shown unique prognostic value. We try to further confirm the prognostic role of me...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Peng, Yu, Tao, Pan, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796872/
https://www.ncbi.nlm.nih.gov/pubmed/33001389
http://dx.doi.org/10.1007/s12149-020-01531-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796872/
https://www.ncbi.nlm.nih.gov/pubmed/33001389
http://dx.doi.org/10.1007/s12149-020-01531-1

Ejemplares similares